Director, Analytical Development (Flow Cytometry & Method Validation)
TLDR
Leads analytical method development and validation for cell therapy programs, with emphasis on advanced flow cytometry, method validation, and regulatory submissions.
Leadership & Strategy
- Provide scientific and operational leadership for the Analytical Development function supporting cell therapy programs.
- Build, mentor, and lead a team of scientists specializing in flow cytometry, cell-based assays, and analytical characterization.
- Define and execute analytical strategies aligned with program, regulatory, and commercialization timelines.
- Collaborate cross-functionally with Process Development, Manufacturing, Regulatory Affairs, QC, and Clinical teams.
- Develop methods related to raw material testing and microbial release tests.
- Lead the development, optimization, and qualification of multiparametric flow cytometry assays for cell identity, purity, potency, and phenotypic characterization.
- Establish standardized panels, controls, and gating strategies for complex cell therapy products (e.g., CAR-T, TCR-T, stem cell-derived therapies).
- Drive innovation in high-dimensional cytometry and data analysis approaches.
- Oversee development, qualification, transfer, and ICH-compliant validation of analytical methods.
- Ensure assays meet regulatory expectations for precision, accuracy, specificity, robustness, and stability.
- Lead comparability studies, reference standard programs, and method lifecycle management.
- Establish an efficient strategy for method validation and transfer.
- Author and review analytical sections of IND, BLA, and other regulatory submissions.
- Serve as a technical subject matter expert during regulatory agency interactions.
- Ensure compliance with cGMP, GLP, and regulatory guidelines.
- Drive continuous improvement in assay robustness, throughput, and scalability.
- Manage budgets, timelines, and resource allocation across multiple programs.
- Oversee technology transfer to Quality Control laboratories.
Flow Cytometry & Cell Therapy Expertise
Analytical Method Development & Validation
Regulatory & Compliance
Operational Excellence
Education & Experience
- Ph.D. in Immunology, Cell Biology, Analytical Chemistry, or related field required
- Minimum 10+ years of industry experience in biotech or pharma
- 8+ years’ experience in experience in cell therapy analytical development (e.g., CAR-T, gene-modified cells, stem cells)
- MSc degree acceptable with 15+ years of relevant experience
- Deep expertise in flow cytometry assay development (multicolor panels, intracellular staining, rare cell detection, functional assays)
- Strong background in analytical method validation (ICH Q2 and regulatory expectations)
- Experience with cell-based potency assays
- Familiarity with advanced cytometry technologies (e.g., spectral cytometry, CyTOF) is a plus
- Strong understanding of CMC development for biologics and cell therapies
- Proven experience leading and developing high-performing teams
- Strong project management and cross-functional leadership skills
- Ability to influence stakeholders at all organizational levels
- Strategic thinking and scientific rigor
- Strong communication and presentation skills
- Results-driven with a focus on quality and compliance
- Ability to manage complexity in a fast-paced environment
Technical Expertise
Leadership Skills
- Experience supporting late-stage clinical programs or commercial products
- Prior experience interacting with FDA/EMA regulatory agencies
- Experience in data analysis tools (FlowJo or equivalent)
- Knowledge of automation and digital data systems in analytical labs
Benefits
Equity Compensation
pre-IPO equity
snacks at on-site locations
snacks at our on-site locations
Health Insurance
competitive medical, dental, and vision benefits
Life and AD&D insurance
life and accidental death and disability coverage
Paid Parental Leave
parental leave benefits
Paid Time Off
PTO
Orca Bio is a biotechnology company focused on advancing the transplant process through innovative cell therapies. By targeting better survival rates and reduced risks, we are transforming how transplantation is approached for patients in need. Our solutions are designed for healthcare providers and patients seeking more effective and safer treatment options.